Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Japan ramps up patent effort to keep iPS lead

Nature volume 453, pages 962–963 (2008)Cite this article

United States in race to commercialize pluripotent stem cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Takahashi, K. et al. Cell 131, 861–872 (2007).

    Article  Google Scholar 

  2. Yu, J. et al. Science 318, 1917–1920 (2007).

    Article  Google Scholar 

  3. Masaki, H. et al. Stem Cell Res. 1, 105–115 (2007).

    Google Scholar 

Download references

Authors
  1. David Cyranoski
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

See also Correspondence: Japan should intensify embryonic stem-cell investigations

Related links

Related links

Related links in Nature Research

Nature Reports Stem Cells

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cyranoski, D. Japan ramps up patent effort to keep iPS lead. Nature 453, 962–963 (2008). https://doi.org/10.1038/453962a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/453962a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing